Search Results - "Minarik, Tomas"

Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients by Kalavska, Katarina, Minarik, Tomas, Vlkova, Barbora, Manasova, Denisa, Kubickova, Michaela, Jurik, Andrej, Mardiak, Jozef, Sufliarsky, Jozef, Celec, Peter, Mego, Michal

“…Patients with ovarian cancer represent a heterogeneous population with a variable prognosis and response to chemotherapy. Plasma DNA has been shown to have a…”
Get full text

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer by Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas

“…AGO‐OVAR 12 investigated the effect of adding the oral triple angiokinase inhibitor nintedanib to standard front‐line chemotherapy for advanced ovarian cancer…”
Get full text

Prognostic value of various subtypes of circulating DNA in ovarian cancer patients by Minarik, Tomas, Vlkova, Barbora, Kalavska, Katarina, Manasova, Denisa, Kubickova, Michaela, Jurik, Andrej, Lengyel, Tibor, Slezak, Igor, Sadovsky, Oliver, Niznansky, Bohumil, Krkoska, Milan, Kocova, Lucia, Mardiak, Jozef, Sufliarsky, Jozef, Celec, Peter, Mego, Michal

“…Abstract only e17092 Background: Patients with ovarian cancer represent a heterogeneous population with a variable prognosis and response to chemotherapy…”
Get full text

Correlation between CD3+ tumor infiltrating lymphocytes and plasma cytokines in primary breast cancer patients by Mego, Michal, Cingelova, Silvia, Cierna, Zuzana, Cholujova, Dana, Janega, Pavol, Karaba, Marian, Gronesova, Paulina, Benca, Juraj, Minarik, Tomas, Labudova, Viera, Pindak, Daniel, Sufliarsky, Jozef, Mardiak, Jozef

“…Abstract only…”
Get full text

Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in primary breast cancer by Karaba, Marian, Mego, Michal, Minarik, Gabriel, Benca, Juraj, Sedlackova, Tatiana, Manasova, Denisa, Sieberova, Gabriela, Hlavata, Zuzana, Jurik, Andrej, Minarik, Tomas, Macuch, Jan, Gronesova, Paulina, Oravcova, Eva, Svabova, Veronika, Sufliarsky, Jozef, Pechan, Juraj, Reuben, James M., Mardiak, Jozef

“…Abstract only e22023 Background: CTCs are prognostic in breast cancer (BC) patients and represent a heterogeneous population of cells with different phenotypes…”
Get full text

Independent review of AGO-OVAR 12, a GCIG/ENGOT-Intergroup phase III trial of nintedanib (N) in first-line therapy for ovarian cancer (OC) by Kristensen, Gunnar, Harter, Philipp, Trédan, Olivier, Sailer, Martin Oliver, Bamias, Aristotelis, Colombo, Nicoletta, Reinthaller, Alexander, Goffin, Frederic, Romeo, Margarita, Ottevanger, Petronella, Kimmig, Rainer, Malander, Susanne, Joly, Florence, De Gregorio, Nikolaus, Mirza, Mansoor Raza, Pfisterer, Jacobus, Minarik, Tomas, Pignata, Sandro, Merger, Michael, Du Bois, Andreas

“…Abstract only…”
Get full text

Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review by Kim, Kun, Hernlund, Emma, Hernadi, Zoltán, Révész, János, Pete, Imre, Szánthó, András, Bodnar, Lubomir, Madry, Rodoslaw, Timorek-Lemieszczuk, Agnieszka, Bozanovic, Tatjana, Vasovic, Suzana, Tomasevic, Zorica, Zivaljevic, Milica, Pazin, Vladimir, Minárik, Tomáš, Garanová, Hana, Helpianska, Lýdia, Justo, Nahila

“…Despite the considerable disease burden of ovarian cancer, there were no cost studies in Central and Eastern Europe. This study aimed to describe treatment…”
Get more information

Tor does not stink: Use and abuse of the Tor anonymity network from the perspective of law by Minárik, Tomáš, Osula, Anna-Maria

“…Tor is one of the most popular technical means of anonymising one's identity and location online. While it has been around for more than a decade, it is only…”
Get full text